Global Patent Index - EP 0805687 A4

EP 0805687 A4 20000531 - RECOMBINANT HUMAN ALPHA-FETOPROTEIN AND USES THEREOF

Title (en)

RECOMBINANT HUMAN ALPHA-FETOPROTEIN AND USES THEREOF

Title (de)

REKOMBINANTES HUMANES ALPHA-FETOPROTEIN UND SEINE VERWENDUNGEN

Title (fr)

ALPHA-F TOPROTEINE HUMAINE RECOMBINANTE ET SES UTILISATIONS

Publication

EP 0805687 A4 20000531 (EN)

Application

EP 96905219 A 19960124

Priority

  • US 9600996 W 19960124
  • US 37730995 A 19950124
  • US 37731195 A 19950124
  • US 37731695 A 19950124
  • US 37731795 A 19950124
  • US 50501295 A 19950721

Abstract (en)

[origin: WO9622787A1] In general, disclosed are methods of inhibiting autoreactive immune cell proliferation in a mammal, involving administering to the mammal a therapeutically effective amount of recombinant human alpha-fetoprotein or an immune cell anti-proliferative fragment or analog thereof; methods of inhibiting a neoplasm in a mammal, involving administering to the mammal a therapeutically effective amount of recombinant human alpha-fetoprotein or an anti-neoplasm fragment or analog thereof; and methods of cell culture, involving the use of a media containing recombinant human alpha-fetoprotein or a fragment or analog thereof.

IPC 1-7

C12N 15/12; C12N 15/62; C07K 14/47; A61K 38/17; C07K 14/00; C12P 21/02

IPC 8 full level

G01N 33/574 (2006.01); A61K 31/435 (2006.01); A61K 31/52 (2006.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61K 47/48 (2006.01); A61K 49/00 (2006.01); A61K 51/00 (2006.01); A61P 3/08 (2006.01); A61P 25/00 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61P 43/00 (2006.01); C07K 14/415 (2006.01); C07K 14/47 (2006.01); C07K 19/00 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12P 21/02 (2006.01); C12R 1/91 (2006.01)

CPC (source: EP)

A61K 38/1709 (2013.01); A61K 47/62 (2017.07); A61P 3/08 (2017.12); A61P 3/10 (2017.12); A61P 5/32 (2017.12); A61P 5/50 (2017.12); A61P 19/02 (2017.12); A61P 21/04 (2017.12); A61P 25/00 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 37/00 (2017.12); A61P 37/06 (2017.12); A61P 43/00 (2017.12); C07K 14/4715 (2013.01); C07K 2319/00 (2013.01); C12N 2799/026 (2013.01)

Citation (search report)

  • [XA] JP H025866 A 19900110 - KANSAI SHIN GIJUTSU KENKYUSHO
  • [XA] EP 0353814 A2 19900207 - SCLAVO SPA [IT]
  • [A] US 5206153 A 19930427 - TAMAOKI TAIKI [CA], et al
  • [A] EP 0001812 A1 19790516 - HOFFMANN LA ROCHE [CH]
  • [A] WO 9305774 A1 19930401 - WISCONSIN ALUMNI RES FOUND [US]
  • [A] MURGITA R. ET AL.: "Adult murine T cells activated in vitro by alpha-fetoprotein and naturally occurring T cells in newborn mice: identity in function and cell surface differentiation antigens", PROC. NATL. ACAD. SCI. USA, vol. 75, no. 6, 1978, pages 2897 - 2901, XP002118046
  • [A] BOISMENU R. ET AL.: "Expression of domains of mouse alpha-fetoprotein in Escherichia coli.", LIFE SCIENCES, vol. 43, no. 8, 1988, pages 673 - 681, XP002118047
  • See references of WO 9622787A1

Designated contracting state (EPC)

AT CH DE FR GB IT LI NL SE

DOCDB simple family (publication)

WO 9622787 A1 19960801; AU 4903596 A 19960814; AU 700975 B2 19990114; CA 2211324 A1 19960801; CA 2211324 C 20120710; CN 1150030 C 20040519; CN 1179106 A 19980415; EP 0805687 A1 19971112; EP 0805687 A4 20000531; HK 1010153 A1 19990617; JP 2008073041 A 20080403; JP H10513347 A 19981222

DOCDB simple family (application)

US 9600996 W 19960124; AU 4903596 A 19960124; CA 2211324 A 19960124; CN 96192764 A 19960124; EP 96905219 A 19960124; HK 98111257 A 19981015; JP 2007243055 A 20070919; JP 52300196 A 19960124